Views & Analysis | Perspectives on pharma industry issues

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Articles

Social media in Indian pharma – are we ready?

Dinesh Chindarkar addresses the rise of mobile and internet use in India and questions whether Indian pharma might be ready to adopt social media. Being one of the fastest growing markets amongst the emerging ones, all eyes are on India. There could not be a more opportune time for...

Articles

A digital pharma day: innovation comes to town

As the conference season hits full swing again, Paul Tunnah gets out and about to see who’s innovating and who’s winning in the world of digital pharma. Last week I found myself attending not one, but two digital pharma events, which provided an excellent opportunity to check the pulse of the industry...

Articles

What makes GSK the number one pharmaceutical company in Egyp...

Nader Rizkalla investigates why GSK is doing so well in Egypt, elaborating on the key success factors in this emerging, but critical, North African market. GSK has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.